{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:15:08Z","timestamp":1760220908010,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hfc.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:10Z","timestamp":1753156810000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotyping the Many Faces of Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"21","author":[{"given":"Paul","family":"Geenty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2025.06.001_bib2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.hfc.2025.06.001_bib3","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a Report of the American heart association\/American College of Cardiology Joint Committee on clinical Practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC State-of-the-Art Review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2025.06.001_bib5","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2025.06.001_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.hfc.2025.06.001_bib7","first-page":"501","article-title":"Improved diagnostic criteria for apical hypertrophic cardiomyopathy","volume":"17","author":"Hughes","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Cardiovascular Imaging"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjmed.2016.09.015","article-title":"Nonobstructive hypertrophic cardiomyopathy out of the shadows: known from the beginning but largely ignored , until now","volume":"130","author":"Maron","year":"2017","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: JACC State-of-the-Art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jcin.2011.02.014","article-title":"Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy","volume":"4","author":"Geske","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.hfc.2025.06.001_bib11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.amjcard.2017.08.047","article-title":"Comparison of valsalva maneuver, amyl nitrite, and exercise echocardiography to demonstrate latent left ventricular outflow obstruction in hypertrophic cardiomyopathy","volume":"120","author":"Ayoub","year":"2017","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2025.06.001_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/01.CIR.86.5.1429","article-title":"Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation","volume":"86","author":"Pellikka","year":"1992","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.echo.2024.02.010","article-title":"Obstruction in hypertrophic cardiomyopathy: many faces","volume":"37","author":"Abbasi","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2025.06.001_bib14","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjcard.2023.10.081","article-title":"Role of imaging in the diagnosis, evaluation, and management of hypertrophic cardiomyopathy","volume":"212","author":"Abraham","year":"2024","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.hfc.2025.06.001_bib15","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.echo.2022.03.012","volume":"35","author":"Nagueh","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"10.1016\/j.hfc.2025.06.001_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2018.06.055","article-title":"Clinical spectrum and management implications of left ventricular outflow obstruction with mild ventricular septal thickness in hypertrophic cardiomyopathy","volume":"122","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.06.001_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2025.06.001_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.echo.2018.10.011","article-title":"Accuracy of jet direction on Doppler echocardiography in identifying the etiology of mitral regurgitation in obstructive hypertrophic cardiomyopathy","volume":"32","author":"Hang","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"21","key":"10.1016\/j.hfc.2025.06.001_bib20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.123.067223","article-title":"Type 1 Brugada pattern may Be Provoked by Ajmaline in some Healthy subjects: results from a clinical Trial","volume":"149","author":"Ensam","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjci\/jes005","article-title":"Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers","volume":"13","author":"Brouwer","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.hfc.2025.06.001_bib23","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2006.08.036","article-title":"Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations","volume":"48","author":"Germans","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"10.1016\/j.hfc.2025.06.001_bib25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","article-title":"Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity","volume":"18","author":"Yang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.hfc.2025.06.001_bib26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.echo.2004.05.018","article-title":"Determinant of left atrial dilation in patients with hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study","volume":"17","author":"Bauer","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"issue":"30","key":"10.1016\/j.hfc.2025.06.001_bib27","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"1, Part C","key":"10.1016\/j.hfc.2025.06.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102146","article-title":"A systematic review and meta-analysis of left atrial strain in hypertrophic cardiomyopathy and its prognostic utility","volume":"49","author":"Hussain","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2025.06.001_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jacc.2019.01.061","article-title":"Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC Review Topic of the Week","volume":"73","author":"Maron","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2025.06.001_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2024.12.010","article-title":"Genes associated with hypertrophic cardiomyopathy: a reappraisal by the clingen hereditary cardiovascular disease gene curation expert panel","volume":"85","author":"Hespe","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.06.001_bib31","article-title":"Sex-specific clinical and genetic factors associated with adverse outcomes in hypertrophic cardiomyopathy","volume":"18","author":"Butters","year":"2025","journal-title":"Circulation: Genomic and Precision Medicine"},{"key":"10.1016\/j.hfc.2025.06.001_bib32","first-page":"422","article-title":"Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals","author":"Schoonvelde","year":"2025","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCULATIONAHA.123.065987","article-title":"Meta-analysis of penetrance and systematic review on transition to disease in genetic hypertrophic cardiomyopathy","volume":"149","author":"Topriceanu","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2025.06.001_bib34","article-title":"Integrating clinical phenotype with multiomics analyses of human cardiac tissue unveils divergent metabolic remodeling in genotype-positive and genotype-negative patients with hypertrophic cardiomyopathy","volume":"17","author":"Nollet","year":"2024","journal-title":"Circulation: Genomic and Precision Medicine"},{"issue":"7","key":"10.1016\/j.hfc.2025.06.001_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2025.06.001_bib36","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0735-1097(01)01389-4","article-title":"On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture","volume":"38","author":"Marian","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.hfc.2025.06.001_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2025.06.001_bib39","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2025.06.001_bib40","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int J Cardiol"},{"issue":"19","key":"10.1016\/j.hfc.2025.06.001_bib42","article-title":"Late phenotypic expression of hypertrophic cardiomyopathy: when to stop looking?","volume":"29","author":"Bavishi","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Case Reports"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/CIRCIMAGING.114.002411","article-title":"Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamacardio.2016.5670","article-title":"The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet Study","volume":"2","author":"Ho","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2025.06.001_bib45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2018180339","article-title":"Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR Feature Tracking","volume":"290","author":"Vigneault","year":"2019","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.hfc.2025.06.001_bib46","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.amjcard.2018.08.008","article-title":"Multilayer myocardial mechanics in genotype-positive left ventricular hypertrophy-negative patients with hypertrophic cardiomyopathy","volume":"122","author":"Williams","year":"2018","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2025.06.001_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","article-title":"Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy","volume":"2","author":"Ho","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.118.037264","article-title":"Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy","volume":"139","author":"Maurizi","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiology"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib50","article-title":"Nonfamilial hypertrophic cardiomyopathy","volume":"10","author":"Ingles","year":"2017","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2025.06.001_bib51","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/CIRCULATIONAHA.121.053527","article-title":"Time to think differently about sarcomere-negative hypertrophic cardiomyopathy","volume":"143","author":"Watkins","year":"2021","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hfc.2025.06.001_bib52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.hfc.2025.06.001_bib53","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/eurheartj\/ehab148","article-title":"Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy","volume":"42","author":"Marston","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2025.06.001_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2025.06.001_bib55","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.hfc.2025.06.001_bib56","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/hmg\/11.20.2499","article-title":"Phenotypic diversity in hypertrophic cardiomyopathy","volume":"11","author":"Arad","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hfc.2025.06.001_bib57","first-page":"400","article-title":"Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: role of age and heart failure phenotypes","author":"Musumeci","year":"2024","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib58","first-page":"1014","article-title":"Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circulation: Heart Fail"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib59","first-page":"967","article-title":"Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy","volume":"7","author":"Rowin","year":"2014","journal-title":"Circulation: Heart Fail"},{"issue":"37","key":"10.1016\/j.hfc.2025.06.001_bib60","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2025.06.001_bib61","first-page":"409","article-title":"Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain","author":"Wazzan","year":"2024","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2025.06.001_bib62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jce.13855","article-title":"The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: a delayed contrast-enhanced magnetic resonance study","volume":"30","author":"Weissler-Snir","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.hfc.2025.06.001_bib63","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2025.06.001_bib64","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2025.06.001_bib65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy","volume":"45","author":"Adabag","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2025.06.001_bib66","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.71.2.234","article-title":"Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures","volume":"71","author":"Cannon","year":"1985","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2025.06.001_bib67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2025.06.001_bib68","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2012.12.024","article-title":"Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy","volume":"61","author":"Karamitsos","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2025.06.001_bib69","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2016.07.751","article-title":"Mechanisms of myocardial ischemia in hypertrophic cardiomyopathy: insights from wave intensity analysis and magnetic resonance","volume":"68","author":"Raphael","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.06.001_bib70","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MAJ.0000000000000194","article-title":"Myocardial bridging as a common phenotype of hypertrophic cardiomyopathy has no effect on prognosis","volume":"347","author":"Tian","year":"2014","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.hfc.2025.06.001_bib71","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.echo.2023.04.020","article-title":"A practical approach to echocardiographic imaging in patients with hypertrophic cardiomyopathy","volume":"36","author":"Mitchell","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"10.1016\/j.hfc.2025.06.001_bib72","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.amjcard.2017.08.048","article-title":"Interaction of adverse disease related pathways in hypertrophic cardiomyopathy","volume":"120","author":"Rowin","year":"2017","journal-title":"Am J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:39:16Z","timestamp":1760218756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713625000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1551713625000509"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2025.06.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotyping the Many Faces of Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}